Skip to Main Content

Rise and shine, everyone, another busy day is on the way. And a fine one it is, here on the Pharmalot campus, where the sun is shining, a breeze is wafting by, and our shortest person is, as usual, sleeping in. As for us, we are quaffing our mandatory cups of stimulation to prepare for the day ahead. As always, we invite you to join us. Remember, no prescription is required. So time to get cracking. Have a lovely day and, of course, do keep in touch …

Theresa May, who is about to become the next UK prime minister, says she wants to shield the country’s pharmaceutical industry from takeovers, Bloomberg News reports. The government nearly allowed AstraZeneca, “one of the jewels” in the crown of the British pharmaceutical industry, to be taken over by Pfizer, a company with a “track record of asset stripping and whose self-confessed attraction to the deal was to avoid tax,” May said.


Doubts over the UK’s ability to win future project grants mean some European Union partners are avoiding working with British researchers, the Guardian tells us. Elite UK universities are coming under pressure to abandon collaborations with European partners. There are instances in which British academics have been asked to leave EU-funded projects or to step down from leadership roles because they are considered a financial liability.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!